|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Oseltamivir binds to and results in decreased activity of AR protein; Oseltamivir binds to and results in increased activity of AR protein |
CTD |
PMID:25752796 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Ces1d |
carboxylesterase 1D |
affects hydrolysis increases metabolic processing multiple interactions |
ISO |
CES1 protein affects the hydrolysis of Oseltamivir CES1 protein results in increased metabolism of Oseltamivir 7,8-dihydromethysticin inhibits the reaction [[CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate]; [CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate; [hirsutine results in decreased activity of CES1 protein] which results in decreased metabolism of Oseltamivir; [mitragynine results in decreased activity of CES1 protein] which results in decreased metabolism of Oseltamivir; [paynantheine results in decreased activity of CES1 protein] which results in decreased metabolism of Oseltamivir; [Plant Extracts results in decreased activity of CES1 protein] which results in decreased metabolism of Oseltamivir; [speciogynine results in decreased activity of CES1 protein] which results in decreased metabolism of Oseltamivir; desmethoxyyangonin inhibits the reaction [[CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate]; dihydrokavain inhibits the reaction [[CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate]; kavain inhibits the reaction [[CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate]; methysticin inhibits the reaction [[CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate]; yangonin inhibits the reaction [[CES1 protein results in increased metabolism of Oseltamivir] which results in increased abundance of oseltamivir carboxylate] |
CTD |
PMID:18983829 PMID:35278473 PMID:37716419 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Il6 |
interleukin 6 |
decreases response to substance |
ISO |
IL6 protein results in decreased susceptibility to Oseltamivir |
CTD |
PMID:17537833 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
Oseltamivir binds to and results in increased activity of PGR protein |
CTD |
PMID:25752796 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
decreases expression |
ISO |
Oseltamivir results in decreased expression of SLC7A11 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions increases expression |
ISO |
Mevalonic Acid affects the reaction [perillic acid results in increased expression of RHOA protein] |
CTD |
PMID:12671036 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rhob |
ras homolog family member B |
multiple interactions increases expression |
ISO |
Mevalonic Acid affects the reaction [perillic acid results in increased expression of RHOB protein] |
CTD |
PMID:12671036 |
|
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
|
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression |
ISO |
MIR300 mRNA affects the reaction [Shikimic Acid results in increased expression of CCND1 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Shikimic Acid results in increased expression of CCND1 mRNA] Shikimic Acid results in increased expression of CCND1 mRNA; Shikimic Acid results in increased expression of CCND1 protein |
CTD |
PMID:31048002 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression multiple interactions |
ISO |
Shikimic Acid results in decreased expression of CDKN1A mRNA; Shikimic Acid results in decreased expression of CDKN1A protein MIR300 mRNA affects the reaction [Shikimic Acid results in decreased expression of CDKN1A protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Shikimic Acid results in decreased expression of CDKN1A mRNA] |
CTD |
PMID:31048002 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
increases expression |
ISO |
Shikimic Acid results in increased expression of FGF7 mRNA |
CTD |
PMID:15265014 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Igf1 |
insulin-like growth factor 1 |
increases expression |
ISO |
Shikimic Acid results in increased expression of IGF1 mRNA |
CTD |
PMID:15265014 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Mir300 |
microRNA 300 |
increases expression multiple interactions |
ISO |
Shikimic Acid results in increased expression of MIR300 mRNA MIR300 mRNA affects the reaction [Shikimic Acid results in decreased expression of CDKN1A protein]; MIR300 mRNA affects the reaction [Shikimic Acid results in decreased expression of NFKBIA mRNA]; MIR300 mRNA affects the reaction [Shikimic Acid results in decreased expression of NFKBIA protein]; MIR300 mRNA affects the reaction [Shikimic Acid results in increased expression of CCND1 protein]; MIR300 mRNA affects the reaction [Shikimic Acid results in increased expression of PCNA protein]; MIR300 mRNA affects the reaction [Shikimic Acid results in increased phosphorylation of RELA protein] |
CTD |
PMID:31048002 |
|
NCBI chr 6:128,738,513...128,738,591
Ensembl chr 6:128,738,505...128,738,594
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
decreases expression multiple interactions |
ISO |
Shikimic Acid results in decreased expression of NFKBIA mRNA MIR300 mRNA affects the reaction [Shikimic Acid results in decreased expression of NFKBIA mRNA]; MIR300 mRNA affects the reaction [Shikimic Acid results in decreased expression of NFKBIA protein]; Shikimic Acid results in decreased expression of and results in decreased phosphorylation of NFKBIA protein |
CTD |
PMID:31048002 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions increases expression |
ISO |
MIR300 mRNA affects the reaction [Shikimic Acid results in increased expression of PCNA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Shikimic Acid results in increased expression of PCNA mRNA] Shikimic Acid results in increased expression of PCNA mRNA; Shikimic Acid results in increased expression of PCNA protein |
CTD |
PMID:31048002 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases phosphorylation multiple interactions |
ISO |
Shikimic Acid results in increased phosphorylation of RELA protein MIR300 mRNA affects the reaction [Shikimic Acid results in increased phosphorylation of RELA protein] |
CTD |
PMID:31048002 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression increases expression |
ISO |
Shikimic Acid results in decreased expression of VEGFA mRNA Shikimic Acid results in increased expression of VEGFA mRNA |
CTD |
PMID:15265014 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|